Purple Biotech Ltd. (PPBT) stock
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.00 (0.00%)
Close on Nov 18, 2026Market cap $1.59MP/E 0.0Yield –
Purple Biotech free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$5.66M. The highest annual figure on record is $1.55M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.66M | – |
| FY2023 | Dec 31, 2023 | -$19.93M | – |
| FY2022 | Dec 31, 2022 | -$16.76M | – |
| FY2021 | Dec 31, 2021 | -$489.00K | -131.6% |
| FY2020 | Dec 31, 2020 | $1.55M | – |
| FY2019 | Dec 31, 2019 | -$1.98M | – |
| FY2018 | Dec 31, 2018 | -$8.50M | – |
| FY2017 | Dec 31, 2017 | -$8.64M | – |
| FY2016 | Dec 31, 2016 | -$6.27M | – |
| FY2015 | Dec 31, 2015 | -$3.32M | – |
See a number that looks wrong?